Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Joe Ensor, PhD"'
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 2, Pp 172-178 (2019)
Objectives: The goal of this study was to compare the risk of cardiotoxicity with osimertinib versus all other drugs and versus epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) (erlotinib, afatinib, and gefitinib) in the U.
Externí odkaz:
https://doaj.org/article/50220951c1c64cb08a7fcb5a1138cf47
Autor:
Anand K; Kartik Anand, MD, Great Plains Health, North Platte, NE and Joe Ensor, PhD, Houston Methodist Research Institute, Houston, TX., Ensor J; Kartik Anand, MD, Great Plains Health, North Platte, NE and Joe Ensor, PhD, Houston Methodist Research Institute, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jun 20; Vol. 39 (18), pp. 2049-2050. Date of Electronic Publication: 2021 Apr 23.